Heart Muscle Patches Show Early Promise for Restoring Failing Hearts
Engineered cardiac patches called BioVAT improved heart function and quality of life in early-stage heart failure patients.
1.236 artigos
Engineered cardiac patches called BioVAT improved heart function and quality of life in early-stage heart failure patients.
A JAMA study found pregnant women sitting 10+ hours daily had twice the risk of preeclampsia, gestational diabetes, and preterm birth.
Engineered heart muscle patches from stem cells thickened weakened heart walls and improved pumping ability in a small human trial.
Xenotransplantation, 3D bioprinting, and stem cell therapies are converging to solve the global organ shortage crisis.
Aalto University researchers found that gentle near-infrared heat can trigger eye cells' natural repair systems, potentially stopping dry AMD early.
New PET imaging finds no widespread brain inflammation in long COVID patients — pointing instead to heightened activity in stress and emotion regions.
UPenn researchers found that blocking GPNMB antibodies halted Parkinson's cell-to-cell spread in lab experiments, opening a path to disease-slowing treatments.
New research shows cardiovascular health drops sharply during perimenopause, making it a critical window for early intervention.
South Korea's hypertension guidelines now recommend cuffless ring monitors, marking a milestone for wearable BP tracking in clinical practice.
Gene therapies and exon-skipping drugs for Duchenne and myotonic dystrophy are nearing FDA submission, with launches potentially by 2027.
Alzinova's ALZ-101 vaccine showed no dangerous brain swelling and triggered lasting antibody responses, clearing the path to a global Phase 2 trial.
Scribe Therapeutics launches first human trial of STX-1150, an epigenetic therapy silencing PCSK9 to slash LDL without permanently altering DNA.